MEDS · DataMEDS AI, Inc.

Wellgistics Health faces significant regulatory and operational developments. The collaboration agreement with Kare entities establishes a joint venture structure where Wellgistics gains majority control (51%) of Healthstar Technologies in exchange for up to $2 million in unregistered common stock. This transaction provides Wellgistics with intellectual property assets while creating a partnership that integrates both companies' technology platforms. Concurrently, the company received a Nasdaq delisting notification due to failing the minimum stockholders' equity requirement of $2.5 million, with reported equity of $(12,447,801) as of December 31, 2025. The company now has a 45-day window to submit a compliance plan, with potential for up to 180 days to demonstrate compliance if Nasdaq accepts the plan. The joint venture aims to combine Wellgistics' pharmacy network and AI platforms with Kare's digital hub capabilities, targeting improved pharmaceutical access and fulfillment across an estimated 200,000+ patient lives. Both developments carry material implications for the company's capital structure, regulatory standing, and strategic direction in the healthcare technology sector.